News

Izotropic CEO Interview - Clinical Trials Soon? (CSE:IZO)

Izotropic CEO Dr. John McGraw joins Justin today to give a high level overview of the stages for Clinical Trials with a timeline update for Izotropic Corp. Dr John McGraw goes over what makes the IzoView so unique compared to its competitors!
IZO
April 26, 2022

Izotropic CEO Dr. John McGraw joins Justin today to give a high level overview of the stages for Clinical Trials with a timeline update for Izotropic Corp. Dr John McGraw goes over what makes the IzoView so unique compared to its competitors!

Izotropic Corporation is the only publicly-traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers.IzoView produces high resolution breast images in true 3D with low radiation dose levels,and is ideal for imaging patients with dense breast tissue. A single 10 second scan acquires approximately 500 images, without painful breastcompression or continual technician breast handling, providing a more comfortable patient experience.

https://izocorp.com‍

CSE:IZO | OTCQB:IZOZF